Tag Archives: (ULIHF)

How One Smug Dane Made Me Eat My Words

Back in 2008, I found myself in a private dining room at Copenhagen’s Noma restaurant – then barely known outside culinary circles – seated next to a senior Novo Nordisk (NVO) executive who couldn’t stop talking about their early-stage GLP-1 research. “This will change diabetes treatment forever,” he insisted between bites of moss and lichen. […]